Axa’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-167,383
Closed -$15M 1265
2021
Q4
$15M Sell
167,383
-2,841
-2% -$241K 0.04% 412
2021
Q3
$13.2M Sell
170,224
-9,565
-5% -$719K 0.04% 425
2021
Q2
$12.9M Buy
179,789
+42,500
+31% +$3.09M 0.04% 463
2021
Q1
$9.3M Buy
137,289
+33,700
+33% +$2.34M 0.03% 535
2020
Q4
$7.58M Hold
103,589
0.02% 590
2020
Q3
$7.25M Sell
103,589
-7,083
-6% -$555K 0.03% 539
2020
Q2
$8.05M Sell
110,672
-10,000
-8% -$712K 0.03% 490
2020
Q1
$7.45M Buy
120,672
+71,686
+146% +$4.38M 0.04% 430
2019
Q4
$3.21M Buy
48,986
+27,753
+131% +$1.91M 0.01% 730
2019
Q3
$1.68M Buy
21,233
+10,772
+103% +$719K 0.01% 896
2019
Q2
$604K Sell
10,461
-55,540
-84% -$3.26M ﹤0.01% 1062
2019
Q1
$3.46M Sell
66,001
-94,405
-59% -$4.94M 0.01% 739
2018
Q4
$8.48M Sell
160,406
-128,000
-44% -$7.31M 0.04% 467
2018
Q3
$18.3M Sell
288,406
-26,991
-9% -$1.75M 0.07% 321
2018
Q2
$18.4M Sell
315,397
-41,327
-12% -$2.24M 0.07% 301
2018
Q1
$18.3M Buy
356,724
+47,352
+15% +$2.54M 0.07% 310
2017
Q4
$18.4M Sell
309,372
-3,329
-1% -$202K 0.07% 319
2017
Q3
$18.4M Buy
312,701
+67,700
+28% +$4.04M 0.08% 289
2017
Q2
$13.7M Buy
245,001
+96,500
+65% +$5.34M 0.06% 349
2017
Q1
$7.64M Sell
148,501
-91,842
-38% -$4.51M 0.03% 493
2016
Q4
$10.8M Buy
+240,343
New +$10.6M 0.05% 392
2014
Q3
Sell
-43,500
Closed -$1.08M 1500
2014
Q2
$1.08M Hold
43,500
﹤0.01% 902
2014
Q1
$906K Buy
+43,500
New +$947K ﹤0.01% 940

Other funds holding CONE

Axa's CONE Position: Q1 2022 in Review

Axa sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 167,383 shares — an estimated $15M sold.

Axa first reported a position in CONE in Q1 2014 and held it in 23 quarters. The position peaked at $18.4M in Q3 2017. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Axa reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Axa sold 167,383 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $15M.
  • Axa first reported a position in CyrusOne Inc Common Stock in Q1 2014 and held it in 23 quarters.
  • Axa's CyrusOne Inc Common Stock position peaked at $18.4M in Q3 2017.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.